CONTACT INFORMATIONBIOGRAPHYCREDENTIALSAWARDSCLINICAL TRIALSPUBLICATIONSVIDEOSHong Zhang, M.D., Ph.D.Contact InformationPhone NumbersAppointment: (585) 341-6750Office: (585) 341-6750Fax: (585) 275-1531A member of the University of Rochester Medical Faculty GroupgroupAn Accountable Health PartnerassignmentAccepting New PatientsLocationsNoyes Memorial Hospital Radiation Oncology111 Clara Barton St, Floor BDansville, NY 14437-9503Radiation Oncology: (585) 335-8675Faculty AppointmentsProfessor - Department of Radiation Oncology (SMD) Patient Care SettingsCancer, Imaging Sciences, Radiation OncologyBiographyIt is a privilege to care for our patients. I am committed to providing personalized radiation treatment of the highest quality, as well as compassionate care. My areas of expertise include prostate and head and neck cancers. Conditions I Treat: - Prostate cancer - Head and neck cancers - Breast cancer - Other cancersCredentialsEducation1993PHD | Case Western Reserve University School of Medicine2001MD | Yale UniversityPost-doctoral Training & Residency07/01/2002 - 06/30/2006Residency in Radiation Oncology at University of Rochester Medical Center06/01/2001 - 06/01/2002Internship in Internal Medicine at Rochester General Hospital06/01/1993 - 12/31/1994Fellowship at Case Western Reserve University Endodontics ResidencyVIEW ALL expand_moreAwards2018Civic Service Award, Us TOO RochesterSponsor: Us TOO Rochester2017AAMC Mid-Career Woman Faculty Leadership Development Seminar 12/2017Sponsor: AAMC2017Health Care Achievement Awards--Health Care InnovationSponsor: Rochester Business JournalLocation: Rochester, NY2016Educator of the YearSponsor: Association of Residents in Radiation Oncology2013Patient- and Family- Centered ICARE High Performance Award2012 - 2017Civic Service Award, Us TOO RochesterSponsor: Us TOO Rochester2012Educator of the YearSponsor: Association of Residents in Radiation Oncology2012Patient- and Family-Centered ICARE High Performance AwardSponsor: University of Rochester Medical Center2005Upstate New York Society of Therapeutic Radiology and Oncology Fall Meeting Resident Presenter AwardLocation: Syracuse, NY2005ASTRO Translational Research in Radiation Oncology Symposium Travel Grant Award2001Janet M.Glasgow Memorial Achievement CitationsSponsor: Yale University School of MedicineLocation: New Haven, Connecticut2000Clyde Swift Award for Outstanding Medical StudentSponsor: Yale University School of MedicineLocation: New Haven, ConnecticutVIEW ALL expand_moreClinical TrialsRandomized Phase III Trial Incorporating Abiraterone Acetate With Prednisone and Apalutamide and Advanced Imaging Into Salvage Treatment for Patients With Node-Positive Prostate Cancer After Radical Prostatectomy,Randomized Phase III Trial Incorporating Abiraterone Acetate With Prednisone and Apalutamide and Advanced Imaging Into Salvage Treatment for Patients With Node-Positive Prostate Cancer After Radical ProstatectomyLead Researcher: Hong Zhang This phase III trial studies whether adding apalutamide to the usual treatment improves outcome in patients with lymph node positive prostate cancer after surgery. Radiation therapy uses high energy x-ray to kill tumor cells and shrink tumors. Androgens, or male sex hormones, can cause the growth of prostate cancer cells. Drugs, such as apalutamide, may help stop or reduce the growth of prostate cancer cell growth by blocking the attachment of androgen to its receptors on cancer cells, a mechanism similar to stopping the entrance of a key into its lock. Adding apalutamide to the usual hormone therapy and radiation therapy after surgery may stabilize prostate cancer and prevent it from spreading and extend time without disease spreading compared to the usual approach. View Study Details PublicationsJournal Articles2022Kerns SL; Amidon Morlang A; Lee SM; Peterson DR; Marples B; Zhang H; Bylund K; Rosenzweig D; Hall W; De Ruyck K; Rosenstein BS; Stock RG; Gómez-Caamaño A; Vega A; Sosa-Fajardo P; Taboada-Valladares B; Aguado-Barrera ME; Parker C; Veldeman L; Fonteyne V; Bultijnck R; Talbot CJ; Symonds RP; Johnson K; Rattay T; Webb A; Lambrecht M; de Ruysscher D; Vanneste B; Choudhury A; Elliott RM; Sperk E; Herskind C; Veldwijk MR; Rancati T; Avuzzi B; Valdagni R; Azria D; Farcy Jacquet MP; Chang-Claude J; et al. "Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer". Radiother Oncol. 2022; 168: 75-82.2022Zhang H; Yang H; Bandyopadhyay S; Milano MT; Fung C; Messing EM; Chen Y. "Increased risk of high-grade prostate cancer among testicular cancer survivors". PLoS One. 2022; 17(2): e0263573.5/2021Zhang H, Yu A, Baran A, Messing E. "Risk of second cancer among young prostate cancer survivors." Radiation oncology journal.. 2021 May; 39(2):91-98. Epub 2021 Jun 28. Books & Chapters2009 Chapter Title: Breast Cancer Book Title: Principles and Practice of Radiation Therapy Author List: Uschold G; Zhang H Edited By: Washington CM; Leaver D Published By: Mosby Elsevier 2009VIEW ALL PUBLICATIONSVideosplay_circle_filledRadiation Oncology at Highland HospitalClose WindowSchedule an appointment with Hong Zhang, M.D., Ph.D.Please answer the following questions to help us find the right appointment for you.Important: If you believe that you have a medical or psychiatric emergency, please call 911 or go to the nearest hospital. This website is not intended for emergency care.Have you seen this provider in the last 2 years?YesNoExisting Patient Schedule or request a follow up appointment online through MyChart. If you do not have a MyChart account, please close this window and call the appointment phone number. Hong Zhang, M.D., Ph.D. is currently scheduling for the following appointment type(s): Our policy does not permit patients to establish care with multiple providers within the same practice or specialty without prior approval. If you choose a new provider in the same office, we will cancel the appointment. Please contact the office directly with questions on this policy.